Client: Large pharma company
Project: Find optimal pharma partner for phase I
program
Assessed valuation of a phase I clinical program
in obesity
- Defined market value (rNPV projections, benchmarking)
- Examined future clinical development & financial consequences
- Performed competitive analysis
Developed partnering strategy
- Ranked potential partnering candidates
- Generated non-confidential & confidential
materials
- Initiated/reactivated and aligned partner contacts
- Prepared and coordinated due diligence processes
Implemented the partnering strategy
- Initiated and managed partnering meetings and
due diligence processes
- Developed optimal deal structures
- Aligned term sheets and supported negotiations
Facilitated deal closing
- Utilized competitive forces by negotiating with
four of the top ten pharma companies
- Improved offered terms five-fold
|
|
